Panel to tackle global data disclosure challenge

Developing a new drug for a global market presents every biopharma company with a complex regulatory challenge. How can you juggle the demands of regulators in Europe and the U.S., as well as other key markets around the globe?

Join us for a unique webinar that will provide expert perspectives on maintaining fruitful relationships with a variety of regulatory agencies, with a special focus on the crucial regulatory communications required on the disclosure of clinical trial data.

We'll cover salient data disclosure requirements from around the world.

Christine Dingivan, M.D., Executive Vice President and Chief Medical Officer, PPD and Patricia Teden, Principal, Teden Consulting will be on hand to provide expert advice on managing global data disclosure challenges. The webinar will take place Thursday, June 24 at 2pm EST.

Click here to register. - George Miller

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

Roche will spend $500 million for a new global manufacturing logistics hub in Canada that will eventually employ 500 workers in Ontario.

Fledgling Indiana CDMO Incog BioPharma Services is shelling out $60 million to get its first manufacturing facility off the ground.